- Home
- VALN vs PSBD Comparison
VALN vs PSBD Comparison
Compare VALN & PSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- PSBD
- Stock Information
- Founded
- VALN 2012
- PSBD 2009
- Country
- VALN France
- PSBD United States
- Employees
- VALN N/A
- PSBD N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- PSBD
- Sector
- VALN Health Care
- PSBD
- Exchange
- VALN Nasdaq
- PSBD Nasdaq
- Market Cap
- VALN 595.2M
- PSBD 507.0M
- IPO Year
- VALN 2021
- PSBD 2024
- Fundamental
- Price
- VALN $7.44
- PSBD $15.30
- Analyst Decision
- VALN Strong Buy
- PSBD Buy
- Analyst Count
- VALN 2
- PSBD 7
- Target Price
- VALN $17.00
- PSBD $16.93
- AVG Volume (30 Days)
- VALN 81.7K
- PSBD 18.1K
- Earning Date
- VALN 03-20-2025
- PSBD 03-03-2025
- Dividend Yield
- VALN N/A
- PSBD 12.37%
- EPS Growth
- VALN N/A
- PSBD N/A
- EPS
- VALN N/A
- PSBD N/A
- Revenue
- VALN $176,817,979.00
- PSBD N/A
- Revenue This Year
- VALN $22.73
- PSBD N/A
- Revenue Next Year
- VALN $11.39
- PSBD N/A
- P/E Ratio
- VALN N/A
- PSBD N/A
- Revenue Growth
- VALN N/A
- PSBD N/A
- 52 Week Low
- VALN $3.62
- PSBD $15.12
- 52 Week High
- VALN $9.50
- PSBD $17.09
- Technical
- Relative Strength Index (RSI)
- VALN 60.56
- PSBD 41.31
- Support Level
- VALN $6.62
- PSBD $15.30
- Resistance Level
- VALN $8.42
- PSBD $15.74
- Average True Range (ATR)
- VALN 0.46
- PSBD 0.35
- MACD
- VALN 0.05
- PSBD -0.04
- Stochastic Oscillator
- VALN 69.85
- PSBD 2.60
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.
About PSBD Palmer Square Capital BDC Inc.
Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.